Stock listing

COCP Stock Price, News, Filings & Events — Cocrystal Pharma, Inc.

Selected listing: COCP · NASDAQ · USD · US

This page tracks Cocrystal Pharma, Inc.'s COCP:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following COCP:NASDAQ. COCP:NASDAQ is the stock-level entry point for investors researching Cocrystal Pharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cocrystal Pharma, Inc. is a public company traded on the American stock market under the ticker COCP. The company has a market capitalization of approximately $12.4 million. Cocrystal Pharma focuses on developing antiviral therapeutics for various diseases.

COCP:NASDAQUSDUSUpdated August 14, 2026
Cocrystal Pharma, Inc. logo
Ticker
COCP:NASDAQ
Asset type
Stock
Market cap
$15.4M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD

Cocrystal Pharma, Inc. COCP:NASDAQ stock context

This page tracks Cocrystal Pharma, Inc.'s COCP:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following COCP:NASDAQ. COCP:NASDAQ is the stock-level entry point for investors researching Cocrystal Pharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cocrystal Pharma, Inc. is a public company traded on the American stock market under the ticker COCP. The company has a market capitalization of approximately $12.4 million. Cocrystal Pharma focuses on developing antiviral therapeutics for various diseases.

Research Cocrystal Pharma, Inc.

Alternate listings